Not only is Vermont small and rural, but it’s also old. Currently, the state is ranked fourth in the nation for the relative number of residents over 65 years old – a whopping nearly 20 percent of Vermont’s population and rising. And with that status comes a disproportionately large share of heart disease, as well as blood vessel diseases and brain circulation problems that can lead to dementia and Alzheimer’s disease.

UVM and University of Maryland researchers have shown how the brain communicates to blood vessels when in need of energy, and how these blood vessels respond to direct blood flow to specific brain regions -- information that can help determine what goes wrong in conditions like Alzheimer’s disease and dementia, where faulty blood flow is a predictor for cognitive impairment.

New trial results from the University of Vermont and an international team of researchers show that administering a full dose of a standard blood thinner early to moderately ill hospitalized patients with COVID-19 could reduce the risk of severe disease and death.

On Friday, June 11, 2021, Phil Ades, MD, associate director of VCBH and director of cardiac rehabilitation in the Division of Cardiovascular Medicine at the UVM Medical Center, received the UVM Larner College of Medicine's Department of Medicine’s Distinguished Mentor Award.

The CVRI Early Career Advisory Committee recently funded research applicatinos through its initiative to support research projects conceived and developed by early career investigators.

University of Vermont Provost and Senior Vice President Patty Prelock has announced that David Warshaw, Ph.D., professor and chair of molecular physiology and biophysics at the UVM Larner College of Medicine, is a 2021 recipient of the University Distinguished Professor Award – the highest academic honor that UVM can bestow upon a member of the faculty.